Cozyme

Cozyme (Coenzyme Q10) is indicated for Coenzyme Q10 deficiency and mitochondrial disorders. It is also used as adjunctive therapy in congestive heart failure, myocardial infarction, and high blood pressure (hypertension). Additional uses include prevention of migraine headache, supportive management of Parkinson's disease, improvement of immune function, male infertility, and muscular dystrophy.

Dosage should be individualised based on the condition being treated and the patient's clinical response. Pharmacokinetic data indicate that divided daily dosing is superior to a single daily dose.

General supplementation

The commonly used range is 50–200 mg orally per day, given in divided doses.

Congestive heart failure

100 mg per day orally, divided into two to three doses.

Myocardial preservation

200 mg per day orally.

For this 30 mg capsule, multiple capsules will typically be required to reach the therapeutic dose. Capsules should be taken with a full glass of water (240–360 mL). Dividing the total daily dose into two or three smaller doses throughout the day may help reduce gastrointestinal side effects.

Capsules should be swallowed whole with a full glass of water (240–360 mL). Dividing the total daily dose into two or three doses taken throughout the day is preferred over a single daily dose, as this improves absorption and reduces gastrointestinal side effects.

Coenzyme Q10 (Ubidecarenone) is a naturally occurring, vitamin-like substance found in virtually all human cells. It plays a central role in the mitochondrial electron transport chain, where it facilitates the production of adenosine triphosphate (ATP) — the primary energy currency of the cell. In addition to its role in cellular energy metabolism, Coenzyme Q10 acts as a lipid-soluble antioxidant, protecting cell membranes and mitochondrial components from oxidative damage.

Coenzyme Q10 also appears to have a modest blood pressure–lowering effect, though the precise mechanism requires further study. In conditions where endogenous CoQ10 levels are depleted — such as in patients taking statin medications, or in primary mitochondrial disorders — supplementation helps restore normal cellular energy production.

Coenzyme Q10 is generally well tolerated. Adverse effects, when they occur, are predominantly gastrointestinal and are reported in fewer than 1% of patients. All reported effects are reversible.

Gastrointestinal: Nausea, vomiting, diarrhoea, loss of appetite, heartburn, epigastric discomfort, and stomach upset. These effects may be reduced by dividing the daily dose.

Hepatic: Elevated liver enzyme levels have been reported; use with caution in patients with hepatic impairment.

Cardiovascular: Lowered blood pressure may occur, particularly in patients already taking antihypertensives.

Dermatological: Allergic skin rash has been reported rarely.

No serious adverse effects have been reported at any documented dose level.

• Known hypersensitivity or allergy to Coenzyme Q10 (Ubidecarenone) or any excipient in the capsule formulation.
• Use is not recommended during pregnancy or breastfeeding, as safety data are not available.
• Not recommended for children and adolescents under 18 years of age unless directed by a physician.

Use with caution in the following situations

• Hepatic impairment or biliary obstruction: Coenzyme Q10 is metabolised in the liver and excreted in bile; impaired clearance may increase exposure.
• Hypertension treated with antihypertensives: Monitor blood pressure, as additive lowering effects may occur.
• Concurrent chemotherapy or radiation therapy: Consult a treating oncologist before initiating Coenzyme Q10, as its antioxidant properties may theoretically interact with some treatment regimens.
• Pre-surgical patients: Discontinue use at least 14 days before any planned surgical procedure.
• Patients with pre-existing medical conditions: A healthcare professional should be consulted before starting therapy.
• Keep out of the reach and sight of children.

Paediatric patients (under 18 years): Not recommended for use in children or adolescents unless specifically directed by a physician.

Elderly patients: No specific dose adjustment has been established; however, elderly patients should be monitored for blood pressure changes, particularly if they are taking antihypertensive medicines.

Hepatic impairment: Use with caution, as Coenzyme Q10 is primarily metabolised and excreted via the liver and bile. Patients with biliary obstruction or significant hepatic insufficiency may experience altered drug exposure.

Patients on concurrent medications: Patients taking warfarin, antidiabetic agents, antihypertensives, statins, or chemotherapy agents should seek medical advice before use.

The safety of Coenzyme Q10 during pregnancy and breastfeeding has not been established. No adequate clinical data are available. Use during pregnancy or lactation is not recommended. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before taking this product.

No specific overdose threshold has been established for Coenzyme Q10. In the event of accidental overdose or ingestion of an unusually large quantity, seek immediate medical assistance or contact a Poison Control Centre. Symptomatic and supportive care should be provided as appropriate.

Coenzyme Q10 has no known severe or serious interactions with other drugs. The following mild interactions have been identified:

• Anticoagulants (e.g., warfarin): Coenzyme Q10 may reduce the anticoagulant effect of warfarin. Patients taking blood-thinning medicines should exercise caution and have their clotting parameters monitored.
• Antihypertensives: Coenzyme Q10 may have an additive blood pressure–lowering effect when used with antihypertensive agents. Blood pressure should be monitored.
• Antidiabetic agents (insulin, sulfonylureas): Coenzyme Q10 may enhance glucose-lowering effects. Blood glucose should be monitored when used alongside these medicines.
• Statins (e.g., atorvastatin, lovastatin, simvastatin): Statins reduce endogenous CoQ10 synthesis; concurrent supplementation may be considered clinically relevant but does not represent a harmful drug–drug interaction per se.
• Herbal or nutritional supplements with blood pressure–lowering properties: Avoid combining with other such supplements without medical advice, as additive hypotensive effects may occur.
• Chemotherapy and radiation therapy: Use with caution in patients undergoing cancer treatment; consult an oncologist before use.

What is the price of Cozyme 30 mg in Bangladesh (BD)?

Cozyme 30 mg price in Bangladesh is ৳8.05 per capsule. Prices may vary by pharmacy and are updated regularly on this page.

What is Cozyme used for?

Cozyme (Coenzyme Q10) is indicated for Coenzyme Q10 deficiency and mitochondrial disorders. It is also used as adjunctive therapy in congestive heart failure, myocardial infarction, and high blood pressure…

Is Cozyme an antibiotic?

No, Cozyme is not an antibiotic.